What does LD&C Medical do?

LD&C Medical is a wholesaler in Comblain-au-Pont. Private Limited, started on 12 October 2016, 1 establishment.

What is the address of LD&C Medical?

The registered office of LD&C Medical is located at Quai du Vignoble 46, 4170 Comblain-au-Pont.

Is LD&C Medical still active?

Yes. According to the CBE (16 September 2026) LD&C Medical is active, legal situation “Normale toestand”, started on 12 October 2016.

Is LD&C Medical registered on Peppol?

Yes, LD&C Medical is registered on the Peppol network with ID 0208:0664573328.

What is the enterprise number of LD&C Medical?

The enterprise number of LD&C Medical is BE0664573328.

When was LD&C Medical founded?

LD&C Medical was founded on 12 October 2016.

Who are the directors of LD&C Medical?

According to the 2025 annual accounts, the directors of LD&C Medical are: David LUKANGU.

Is LD&C Medical a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 October 2016; 6 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did LD&C Medical make in 2025?

LD&C Medical posted a profit after taxes of € 7,451 in financial year 2025.

What is the revenue of LD&C Medical?

As a small company, LD&C Medical is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 60,132.

Does LD&C Medical have a website?

Yes, LD&C Medical has a website at ldcmedical.be.

LD&C Medical (Private Limited) - Comblain-au-Pont

Dossier LD&C Medical, printed on 16 September 2026 from databakkes.be/en/0664573328/ld-c-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 35 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

LD&C Medical from Comblain-au-Pont, company number BE0664573328, closed financial year 2025 with a result of € 7,451 after tax. For that financial year LD&C Medical recorded a gross margin of € 60,132 and equity of € 90,994. Compared with financial year 2024, the result moved from € 23,463 to € 7,451. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.

What it is worth Healthy

€ 90,994

▼ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 7,451

▼ 68% vs 2024

Profit after tax over the fiscal year.

Where the profit goes Pays out

€ 22,597 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 30,018

▲ 18% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 260,539

▲ 8% vs 2024

€ 34,937 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 30,085

▲ 170% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 10,934

▼ 41% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 70,029 Gross margin 2022: € 70,029 First fiscal year in the series	€ 71,377 Gross margin 2023: € 71,377 ▲ 2% vs 2022 (€ 70,029) Favourable step	€ 67,171 Gross margin 2024: € 67,171 ▼ 6% vs 2023 (€ 71,377) Unfavourable step	€ 60,132 Gross margin 2025: € 60,132 ▼ 10% vs 2024 (€ 67,171) Unfavourable step	▼ 10%
Profit after taxes	€ 28,009 Profit after taxes 2022: € 28,009 First fiscal year in the series	€ 24,371 Profit after taxes 2023: € 24,371 ▼ 13% vs 2022 (€ 28,009) Unfavourable step	€ 23,463 Profit after taxes 2024: € 23,463 ▼ 4% vs 2023 (€ 24,371) Unfavourable step	€ 7,451 Profit after taxes 2025: € 7,451 ▼ 68% vs 2024 (€ 23,463) Unfavourable step	▼ 68%
Equity	€ 76,733 Equity 2022: € 76,733 First fiscal year in the series	€ 101,104 Equity 2023: € 101,104 ▲ 32% vs 2022 (€ 76,733) Favourable step	€ 106,141 Equity 2024: € 106,141 ▲ 5% vs 2023 (€ 101,104) Favourable step	€ 90,994 Equity 2025: € 90,994 ▼ 14% vs 2024 (€ 106,141) Unfavourable step	▼ 14%
Total debts	€ 256,946 Total debts 2022: € 256,946 First fiscal year in the series	€ 265,033 Total debts 2023: € 265,033 ▲ 3% vs 2022 (€ 256,946) Unfavourable step	€ 288,924 Total debts 2024: € 288,924 ▲ 9% vs 2023 (€ 265,033) Unfavourable step	€ 329,392 Total debts 2025: € 329,392 ▲ 14% vs 2024 (€ 288,924) Unfavourable step	▲ 14%
Cash	-	-	€ 582 Cash 2024: € 582 First fiscal year in the series	-
Land & buildings	€ 148,750 Land & buildings 2022: € 148,750 First fiscal year in the series	€ 141,750 Land & buildings 2023: € 141,750 ▼ 5% vs 2022 (€ 148,750) Unchanged	€ 134,750 Land & buildings 2024: € 134,750 ▼ 5% vs 2023 (€ 141,750) Unchanged	€ 127,750 Land & buildings 2025: € 127,750 ▼ 5% vs 2024 (€ 134,750) Unchanged	▼ 5%
Retained profit	€ 64,333 Retained profit 2022: € 64,333 First fiscal year in the series	€ 88,704 Retained profit 2023: € 88,704 ▲ 38% vs 2022 (€ 64,333) Favourable step	€ 93,741 Retained profit 2024: € 93,741 ▲ 6% vs 2023 (€ 88,704) Favourable step	€ 78,594 Retained profit 2025: € 78,594 ▼ 16% vs 2024 (€ 93,741) Unfavourable step	▼ 16%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 18,426 Dividend 2024: € 18,426 Unchanged (€ 0) Unchanged	€ 22,597 Dividend 2025: € 22,597 ▲ 23% vs 2024 (€ 18,426) Unchanged	▲ 23%
Bank debt	€ 215,577 Bank debt 2022: € 215,577 First fiscal year in the series	€ 228,446 Bank debt 2023: € 228,446 ▲ 6% vs 2022 (€ 215,577) Unfavourable step	€ 240,726 Bank debt 2024: € 240,726 ▲ 5% vs 2023 (€ 228,446) Unfavourable step	€ 260,539 Bank debt 2025: € 260,539 ▲ 8% vs 2024 (€ 240,726) Unfavourable step	▲ 8%
Balance sheet total	€ 333,679 Balance sheet total 2022: € 333,679 First fiscal year in the series	€ 366,136 Balance sheet total 2023: € 366,136 ▲ 10% vs 2022 (€ 333,679) Unchanged	€ 395,065 Balance sheet total 2024: € 395,065 ▲ 8% vs 2023 (€ 366,136) Unchanged	€ 420,385 Balance sheet total 2025: € 420,385 ▲ 6% vs 2024 (€ 395,065) Unchanged	▲ 6%

Key figures of LD&C Medical, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to LD&C Medical?

What happened at LD&C Medical in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 30, 2026 New annual accounts for financial year 2025: profit of € 7,451 (▼ 68% vs 2024). filed late Source: NBB ↗
Oct 12, 2016 New establishment in Comblain-au-Pont. KBO
2016 David LUKANGU became a director. NBB
Oct 12, 2016 Start of the company according to the CBE. KBO

In short

From € 28,009 profit in 2022 to € 7,451 profit in 2025.

Paid € 36,129 in corporate taxes since 2022.

Best year ever: 2022, with € 28,009 profit.

Paid out € 41,023 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at LD&C Medical? We notify you, reason included.

Follow LD&C Medical

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

David LUKANGU

LD&C Medical

Behind LD&C Medical is David LUKANGU.

See the full network in the app

Directors

According to the 2025 annual accounts

David LUKANGU

Director

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Quai du Vignoble 46

4170 Comblain-au-Pont

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS ldcmedical.be

Canonical: https://www.ldcmedical.be/

About

Technologies

ApacheBootstrapGoogle AnalyticsGoogle FontsMasonryPHPjQuery

Hosting & Email

Email provider

Self-hosted

Hosting

Online SAS, FR

Website info

HTTPS Ja

Languages EN, FR, NL

Features

Blog

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number: 0664.573.328
VAT number: BE 0664.573.328
Registered office: Quai du Vignoble 46, 4170 Comblain-au-Pont
Names & denominations: LD&C Medical
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 12 October 2016
Peppol: Active · Active since 14 Nov 2025
Contact: ldcmedical.be
Activities · NACE: Groothandel in farmaceutische en medische artikelen

View on CBE Public ↗ Annual accounts (NBB) ↗